Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancerMartin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Bioorganic & Medicinal Chemistry|May 3, 2016
Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring systemMin Xie, Rena G Lapidus, Mariola Sadowska, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgeryAshish B Patel, Martin J Edelman, Young Kwok, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLCNeha Bhooshan, Paul N Staats, Amy M Fulton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I and pharmacokinetic study of 7-hydroxystaurosporine and carboplatin in advanced solid tumorsMartin J Edelman, Kenneth S Bauer, Suhlan Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A ReviewVictor E Chen, Benjamin A Greenberger, James M Taylor, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2009
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancerMartin J Edelman, Whitney Burrows, Mark J Krasna, et al.
International Journal of Cancer|May 18, 2010
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cellsMinu K Srivastava, Jacobus J Bosch, Ashley L Wilson, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2017
Daily diary study of hope, stigma, and functioning in lung cancer patientsLaurie E Steffen, Kevin E Vowles, Bruce W Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancerMartin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Bioorganic & Medicinal Chemistry|May 3, 2016
Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring systemMin Xie, Rena G Lapidus, Mariola Sadowska, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgeryAshish B Patel, Martin J Edelman, Young Kwok, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLCNeha Bhooshan, Paul N Staats, Amy M Fulton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I and pharmacokinetic study of 7-hydroxystaurosporine and carboplatin in advanced solid tumorsMartin J Edelman, Kenneth S Bauer, Suhlan Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A ReviewVictor E Chen, Benjamin A Greenberger, James M Taylor, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2009
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancerMartin J Edelman, Whitney Burrows, Mark J Krasna, et al.
International Journal of Cancer|May 18, 2010
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cellsMinu K Srivastava, Jacobus J Bosch, Ashley L Wilson, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2017
Daily diary study of hope, stigma, and functioning in lung cancer patientsLaurie E Steffen, Kevin E Vowles, Bruce W Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Pageof 19